Press "Enter" to skip to content

Month: June 2026

Buildings May Soon Have ‘Immune Systems’ That Fight Airborne Disease

Following the pandemic, the federal government is spending $150 million on new technology to ensure clean indoor air. Here’s what scientists are pursuing.

Linsey Marr, an environmental engineer, stood next to a pair of clear plastic boxes packed with tubes, nozzles and electronics, an odd-looking prototype that one day might serve to protect children in day care from airborne pathogens.

A nozzle filled the right-hand box with a faint silvery mist. A pump pulled some of that air into the left-hand box, where a sampler trapped floating particles and droplets. Soon, a digital screen bolted to the box turned red: “Detected! Dust mite allergen Der f 1.”

A protein shed by dust mites, Der f 1 can trigger asthma attacks when inhaled. Dr. Marr’s device had detected 843 picograms of Der f 1 per cubic meter. A single grain of salt is about 10 million times as heavy.

Comments closed

Quebec can no longer remain inactive

The author sounds the alarm on the risks posed by long COVID and demands that Quebec inject money to finance research and treatments

My daughter has been living with COVID for almost two years. She suffers day after day, without access to proper treatment. She endures overwhelming fatigue, brain fog, severe insomnia, trigeminal neuralgia and a disorder of the autonomic nervous system where her heart accelerates abnormally when she stands, causing dizziness, intense fatigue and faintness. She spends almost 20 hours a day in bed. Her husband has had to stop working to take care of her and their two children. I can’t stand by and watch her suffer.

This is not an isolated case: this suffering, sometimes present for six years, is still ignored by our health system, even though the existence of long COVID is firmly established by science.

Comments closed

Long COVID may affect 1 in 6 infected patients

Long COVID may be affecting far more Americans than current estimates suggest, with a study published last week in JAMA Network Open estimating that roughly one in six people infected with SARS-CoV-2 develop the condition, and nearly 90% go on to experience chronic health problems.

For the study, a team led by researchers at Massachusetts General Hospital analyzed health record data from 457,950 adults treated for COVID-19 (also known as postacute sequelae of SARS-CoV-2 infection, or PASC) across 58 hospitals and clinics in New England, Southeast Texas, Southern California, and Western Pennsylvania.

The researchers identified long COVID cases by detecting symptoms and conditions that emerged after infection and could not be explained by preexisting conditions.

Comments closed